Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
35.18
-1.89 (-5.10%)
May 18, 2026, 4:00 PM EDT - Market closed
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $1.68 billion as of May 19, 2026. Its market cap has increased by 306.89% in one year.
Market Cap
1.68B
Enterprise Value
1.22B
1-Year Change
306.89%
Ranking
Category
Stock Price
$35.18
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has increased from $601.40M to $1.68B, an increase of 179.77%. That is a compound annual growth rate of 69.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 1.68B | 16.36% |
| Dec 31, 2025 | 1.45B | 122.86% |
| Dec 31, 2024 | 648.87M | 7.89% |
| Jun 7, 2024 | 601.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascentage Pharma Group International | 1.85B |
| AnaptysBio | 1.84B |
| Sionna Therapeutics | 1.82B |
| Syndax Pharmaceuticals | 1.79B |
| Oculis Holding AG | 1.79B |
| Lakefront Biotherapeutics NV | 1.79B |
| Zymeworks | 1.75B |
| Harmony Biosciences Holdings | 1.74B |